IE000O5M6XO1
IE000O5M6XO1
ARK Genomic Revolution UCITS ETF
Loading chart...
About this ETF
The ETF invests in companies from around the world that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
TER
0.75%
Total Expense Ratio per year
Fund Size
€77.4M
Assets under management
Holdings
33
Underlying equities
Dividend Yield
-
Accumulating
Fundamentals & Estimates
Weighted valuation multiples and analyst forecasts
Valuation Multiples
Weighted P/E
37.81
Weighted Fwd P/E
-22.65
💰 Revenue Estimates
Current Year CY
+46.02% ⌀ 14 Analysts Coverage
Next Year NY
+53.55% ⌀ 14 Analysts Coverage
📈 EPS Estimates (Earnings Per Share)
Current Year CY
+5.77% ⌀ 10 Analysts Coverage
Next Year NY
+49.84% ⌀ 10 Analysts Coverage
Related ETFs
Xtrackers World Small Cap Green Tech Innovators UCITS ETF 1C
39.45 EUR
TER 0.45% 1Y +25.5%
Xtrackers World Green Tech Innovators UCITS ETF 1C
34.94 EUR
TER 0.35% 1Y +15.8%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C
44.06 USD
TER 0.3% 1Y +71.1%
ETF Profile
Provider
Fund Type
ETF Type
Actively Managed Inception Date
04/12/2024 (2 yrs)
Index Group
ARK Genomic Revolution Index
ARK Genomic Revolution Region
World Country
-
Sector
Health Care Strategy
-
Theme
Innovation Distribution Policy
Accumulating Replication
Full replication Sustainable
Yes 🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
Diversification Score: 28/100 Low (Concentration Risk)
Diversification Score
28/100 Low (Concentration Risk)
3Y Volatility
46.0% p.a.
Max Drawdown (3Y)
-44.0%
Sharpe Ratio (3Y)
0.78
Notes & Warnings
Fund Volume (AUM) Solid fund volume
⚠️ Elevated valuation: Avg P/E of 37.8
🟡 Moderate analyst coverage (9.9 analysts)
⚠️ Elevated top 10 holdings concentration: 58% of fund in top 10 positions.
🔴 Severe sector concentration risk: 100% in "Healthcare".
⚠️ Industry concentration: 40% in "Biotechnology".
⚠️ Elevated Regulatory & Policy Risk: 100% in heavily regulated industries (defense, regulated utilities, healthcare policy).